Boots Ireland Expands Weight Loss Services with Prescription Treatments
Boots Ireland is now offering a comprehensive weight loss service, combining professional consultations with access to prescription medications. The initiative aims to address the growing issue of overweight and obesity in Ireland, where over 60% of adults are affected, increasing their risk of heart disease, diabetes and stroke .
Service Details and Eligibility
The Boots weight loss service is designed for adults with a Body Mass Index (BMI) of 30 kg/m² or higher. Individuals with weight-related health conditions, such as diabetes, high blood pressure, or breathing problems, may also be eligible with a lower BMI threshold of 27 kg/m² . The process begins with a consultation, either with a General Practitioner (GP) or through online services.
Following the initial consultation, a 10-minute in-store Weight Check Consultation is conducted by a trained healthcare professional. This assessment includes measuring BMI, waist circumference, and blood pressure, and provides personalized advice. If deemed appropriate, a prescription medication can be provided and collected at the same time .
Ongoing pharmacy weight checks are scheduled as recommended by the doctor to support patients in maintaining their progress. Boots emphasizes the importance of consistency and provides follow-up appointments to ensure patients receive the necessary guidance for sustainable results .
Available Prescription Medications
Boots Ireland offers several prescription weight loss treatments, including:
- Mounjaro: A weekly injectable pen containing tirzepatide, which regulates blood sugar and energy balance, reducing appetite and cravings . Pricing for a single pen ranges from £176.97 to £334.97 depending on the dosage (2.5mg to 15mg) .
- Wegovy: A once-weekly self-injection containing semaglutide, which controls appetite and reduces food cravings. It’s intended for sustained weight loss alongside a reduced-calorie diet and increased physical activity. Semaglutide has also been shown to reduce the risk of heart attack and stroke in adults with heart disease . A single pen costs between £99.97 and £205.97, with a 3-pack of 2.4mg pens available for £285 .
- Orlistat and Xenical: These medications reduce fat absorption in the digestive system .
To continue medication after 12 weeks, patients must demonstrate at least a 5% loss of their initial body weight . Boots provides sharps disposal bins and consultations at no extra charge when recommended .
Additional Support and Resources
Boots provides a 360° support system, including a podcast, live webinars, a 10-week program, exercise videos, a 12-month aftercare plan, and a tracker app to support patients maintain consistency and achieve their weight loss goals .